High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularization.
Spannagl
M
M
Dietrich
W
W
Beck
A
A
Schramm
W
W
D007611:Aprotinin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005112:Extracorporeal Circulation; D005340:Fibrinogen / Q000187:drug effects*; D006801:Humans; D008297:Male; D009204:Myocardial Revascularization / Q000379:methods*; D011516:Prothrombin / Q000187:drug effects*
D011516:Prothrombin; D005340:Fibrinogen; D007611:Aprotinin